ArticleNeurospine2025
Lysophosphatidylcholine Acyltransferase 1-Phosphatidylcholine Axis Protects Nucleus Pulposus Cells From Ferroptosis by Facilitating Lysosomal Repair via Interaction With the Endoplasmic Reticulum.
Article in Neurospine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveIntervertebral disc degeneration (IDD), a prevalent musculoskeletal disorder, imposes significant socioeconomic and health care burdens worldwide. Despite its clinical impact, the molecular mechanisms driving IDD pathogenesis remain poorly characterized, and effective pharmacological interventions are urgently needed. This study elucidated the molecular mechanisms underlying IDD progression through multiomics integration.
methodsWe performed systematic transcriptomic, proteomic, metabolomic, and lipidomic profiling of human degenerated nucleus pulposus (NP) tissues to identify disease-associated molecular signatures and therapeutic targets. Functional validation experiments were conducted using in vitro and ex vivo models of IDD.
resultsMultiomics analyses revealed that lysosomal membrane lipid remodeling plays a critical role in IDD progression. Dysregulation of lysosomal phosphatidylcholine (PC) metabolism caused by reduced lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression led to lysosomal membrane permeabilization (LMP) and subsequent ferroptosis in NP cells. Mechanistically, the LPCAT1-PC axis was identified as a key regulatory pathway: LPCAT1 downregulation in IDD correlated with decreased lysosomal PC content, impaired membrane stability and increased LMP-driven ferroptosis. Conversely, LPCAT1 overexpression increased the number of endoplasmic reticulum-lysosome contact sites, facilitating phospholipid transfer and lysosomal membrane repair. This restoration of lysosomal integrity effectively suppressed ferroptotic cell death.
conclusionOur findings establish the LPCAT1-PC axis as a potential protective mechanism against IDD by maintaining lysosomal homeostasis through interorganellar lipid trafficking. This study provides the first evidence linking lysosomal lipid composition, membrane stability, and ferroptosis in NP cells, offering new therapeutic strategies targeting lipid metabolism and organelle crosstalk for IDD management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.